Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy

Circulation

Volumn 96, Issue 7, 1997, Pages 2190-2196

  Neubauer, Stefan ^a,e   Horn, Michael ^a   Cramer, Monika ^b   Harre, Kerstin ^b   Newell, John B ^c   Pabst, Thomas ^c   Ertl, Georg ^d   Hahn, Dietbert ^d   Ingwall, Joanne S ^a   Kochsiek, Kurt ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Heart failure; Metabolism; Mortality; Spectroscopy, magnetic resonance

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENERGY METABOLISM; FEMALE; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE METABOLISM; HUMAN; MALE; MORTALITY; PHOSPHATE METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

EID: 0030819144     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.7.2190     Document Type: Article

References (45)

1. Ingwall JS. Phosphorus nuclear magnetic resonance spectroscopy of cardiac and skeletal muscles. Am J Pliysiol. 19S2;242:I I729-I744.
2. Bottomley PA. MR spectroscopy of the human heart: the status and the challenges. Radiology. 1994;191:593-612.
3. Schaefer S, Gober JR, Schwartz GG, Twieg DB, Weiner MW, Massie B. In vivo phosphorus-31 spectroscopic imaging in patients with global myocardial disease. Am J Cardiol. 1990;65:1154-1161.
4. Blackledge MJ, Rajagopalan B, Oberhaensli RD, Bolas NM, Styles P, Radda G. Quantitative studies of human cardiac metabolism by 31P rotating-frame NMR. Proc Nail Acad Sei USA. 1987;84: 4283-4287.
5. Grist TM, Kneeland JB, Rilling WR, Jesmanowicz A, Froncisz W, Hyde JS. Gated cardiac MR imaging and P-31 MR spectroscopy in humans at 1.5 T. Radiology. 1989;170:357-361.
6. Auffermann W, Chew W, Wolfe CL, Tavares NJ, Parmley WW, Semelka RC, Donnelly T, Chatterjee K, Higgins CB. Normal and diffusely abnormal myocardium in humans: functional and metabolic characterization with P-31 MR spectroscopy and cine MR imaging. Radiology. 1991;179:253-259.
7. de Roos A, Doornbos J, Luyten PR, Oostenvaal LJMP, van der Waal EE, den Hollander JA. Cardiac metabolism in patients with dilated and hypertrophie cardiomyopathy: assessment with protondecoupled P-31 MR spectroscopy. J Magn Reson Imaging. 1992;2: 711-719.
8. Weiss RG, Bottomley PA, Hardy CJ, Gerstenblith G. Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. N Engl J Med. 1990;323:1593-1600.
9. Yabe T, Mitsunami K, Inubushi T, Kinoshita M. Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 3'P magnetic resonance spectroscopy. Circulation. 1995; 92:15-23.
10. Conway MA, Allis J, Ouwerkerk R, Niioka T, Rajagopalan B, Radda GK. Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy. Lancet. 1991;338:973-976.
11. Neubauer S, Krähe T, Schindler R, Hillenbrand H, Entzeroth C, Hörn M, Bauer WR, Stephan T, Lackner K, Haase A, Ertl G. Cardiac 3'P-magnetic resonance spectroscopy of volunteers and patients with coronary artery disease and dilated cardiomyopathy: altered cardiac high-energy phosphate metabolism in heart failure. Circulation. 1992;S6:1810-1818.
12. Neubauer S, Horn M, Pabst T, Gödde M, Lübke D, Illing B, Hahn D, Ertl G. Contributions of 3'P-magnetic resonance spectroscopy to the understanding of dilated heart muscle disease. Eur Heart J. 1995;16(suppl O):115-118.
13. Hardy CI, Weiss RG, Bottomley PA, Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J. 1991;122:795-801.
14. Neubauer S, Horn M, Naumann A, Tian R, Hu K, Laser M, Friedrich J, Gaudron P, Schnackerz K, Ingwall JS, Ertl G. Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. J Clin Invest. 1995; 95:1092-1100.
15. Markiewicz W, Wu SS, Parmley WW, Higgins CB, Sievers R, James TL, Wikman-Coffelt J, Jasmin G. Evaluation of the hereditary Syrian hamster cardiomyopathy by 31P nuclear magnetic resonance spectroscopy: improvement after acute verapamil therapy. Circ Res. 1986;59:597-604.
16. Ingwall JS, Atkinson DE, Clarke K, Fetters JK. Energetic correlates of cardiac failure: changes in the creatine kinase system in the failing myocardium. Eur Heart J. 1990;II(suppl C):108-115.
17. Shimamoto N, Goto N, Tanabe M, Imamoto T, Fujiwara S, Hirata M. Myocardial energy metabolism in the hypertrophied hearts of spontaneously hypertensive rats. Basic Res Cardiol. 1982;77: 359-371.
18. Nascimben L, Friedrich J, Liao R, Pauletto P, Pessina AC, Ingwall JS. Enalapril treatment increases cardiac performance and energy reserve via the creatine kinase reaction in myocardium of Syrian myopathie hamsters with advanced heart failure. Circulation. 1995; 91:1824-1833.
19. Zhang J, McDonald KM. Bioenergetic consequences of left ventricular remodeling. Circulation. 1995;92:1011-1019.
20. Ingwall JS. On the hypothesis: cardiac failure is due to decreased energy reserve. Circulation. 1993;87[suppl VIl]:VlI-58-VII-62.
21. Cohn JN, Rector TS. Prognosis of congestive heart failure and predictors of mortality. Am J Cardiol. 1988;62:25A-30A.
22. Slachcic J, Massie BM, Kramer BL, Topic N, Tubau J. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol. 1985;55:1037-1042.
23. Gradman A, Deedwania P, Cody R, Massie B, Packer M, Pitt B, Goldstein S. Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol. 19S9;14:564-570.
24. Cohn J, Levine B, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-923.
25. Gottlieb SS, Kukin ML, Ahern D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol. 1989;13:1534-1539.
26. Packer M. Potential role of potassium as a determinant of morbidity and mortality in patients with systemic hypertension and congestive heart failure. Am J Cardiol. 1990;65:45E-51E.
27. Ordidge RJ, Connelly A, Lohman JAB. Image-Selected In vivo Spectroscopy (ISIS): a new technique for spatially selective NMR spectroscopy. J Magn Reson. 1985;66:283-294.
28. Horn M, Neubauer S, Bomhard M, Kadgien M, Schnackerz K, Ertl G. "P-NMR spectroscopy of human blood and serum: first results from volunteers and patients with congestive heart failure, diabetes mellitus and hyperlipidemia. MAGMA. 1993;1:55-60.
29. Norusis M. SPSS Advanced Statistics Version 6.1. Chicago, 111: SPSS Inc; 1994.
30. Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the phosphocreatine circuit for cellular energy homeostasis. Biochem J. 1992;281:21-40.
31. Hamman BL, Bittl JA, Jacobus WE, Ingwall JS. Inhibition of the creatine kinase reaction decreases the contractile reserve of isolated rat hearts. Am J Physiol. 1995;269:H1030-H1036.
32. Zweier JL, Jacobus WE, Korecky B, Brandejs-Barry Y. Bioenergetic consequences of cardiac phosphocreatine depletion induced by creatine analogue feeding. J Biol Chem. 1991;266:20296-20304.
33. van Deussen J, Heerschap A, Oerlemans F, Ruitenbeek W, Jap P, ter Laak H, Wieringa B. Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity. Cell. 1993;74:621-631.
34. Zhang J, Merkle H, Hendrich K, Garwood M, From AHL, Ugurbil K, Bache RJ. Bioenergetic abnormalities associated with severe left ventricular hypertrophy. J Clin Invest. 1993;92:993-1003.
35. Sanbe A, Tanonaka K, Hanaoka Y, Katoh T, Takeo S. Regional energy metabolism of failing hearts following myocardial infarction. J Mol Cell Cardiol. 1993;25:995-1013.
36. Nascimben L, Ingwall JS, Pauletto P, Friedrich J, Gwathmey JK, Saks V, Pessina AC, Allen PD. The creatine kinase system in failing and nonfailing human myocardium. Circulation. 1996;94:1894-1901.
37. Tian R, Nascimben L, Daouk R, Ingwall JS. Depletion of energy reserve via creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamsters. J Mol Cell Cardiol. 1996;28: 755-765.
38. Liao R, Nascimben L, Friedrich J, Gwathmey JK, Ingwall JS. Decreased energy reserve in an animal model of dilated cardiomyopathy. Circ Res. 1996;78:S93-902.
39. Horn M, Neubauer S, Frantz S, Hügel S, Hu K, Gaudron P, Schnackerz K, Ertl G. Preservation of left ventricular mechanical function and energy metabolism in rats post myocardial infarction by the angiotensin converting enzyme inhibitor quinapril. / Cardiovasc Pliarmacol. 1996;27:201-210.
40. Laser A, Neubauer S, Tian R, Hu K, Gaudron P, Ingwall J, Ertl G. Long-term beta-blocker treatment prevents chronic creatine kinase and lactate dehydrogenase system changes in rat hearts postmyocardial infarction. J Am Coll Cardiol. 1996;27:487-493.
41. Pfeffer MA, on behalf of the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1992;327: 669-677.
42. Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med. 1987;316:1429-1435.
43. Swedberg K, Hjalmarson A, Waagstein F, Wallentin I. Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. Br Heart J. 1980;44:117-133.
44. CIBIS Investigators and Committees. A randomized trial of β-blockade in heart failure: the Cardiac Insufficiency BIsoprolol Study (CIBIS). Circulation. 1994;90:1765-1773.
45. Neubauer S, Newell JB, Ingwall JS. Ventricular fibrillation in hypoxia: metabolic consequences and predictability-a 31P- and "Na-NMR study of the isolated rat heart. Circulation. 1992;86: 302-310.